Regulatory Affairs
Dossier preparation, CTD/eCTD, global submissions and regulatory strategy across major markets.
47 videos

Pharma Hub™ - Regulatory Affairs 2026: The New FDA Draft Guidance on Form 483

Pharma Hub™ - What is Regulatory Affairs? | A PharmD in the Pharmaceutical Industry

Pharma Hub™ - Basic Concepts of Pharmaceutical Regulatory Affairs | Drug Regulatory Affairs Interview Questions

Pharma Hub™ - Basic Regulatory Affairs Training (BRAT) 2026 | Free RA for Beginners | Pharmers Academy

Pharma Hub™ - What Is Regulatory Affairs? | The Science Career Nobody Talks About

Pharma Hub™ - What Is Regulatory Affairs? | The Pharma Career Nobody Talks About

Pharma Hub™ - How To Land Your First Job In Regulatory Affairs! (7 Power Tips 2020)

Pharma Hub™ - Regulatory Affairs - Interview Questions & Answers

Pharma Hub™ - Mastering ICH M9: The BCS Biowaiver Blueprint for Pharma

Pharma Hub™ - A Short Guide to the ICH CTD (Common Technical Document)

Pharma Hub™ - ndia’s Clinical Trial Ecosystem: Regulation, Readiness and the Road Ahead | Dr Seema Pai | PHIR

Pharma Hub™ - CTD Module 3 Detailed Breakdown of Quality Module

Pharma Hub™ - Unlocking FDA Approval - Understand IND, NDA & ANDA Like a Pro!

Pharma Hub™ - Drug Approval Process in USA & EU | Step-by-Step FDA & EMA Pathway Explained

Pharma Hub™ - Post Drug Approval Changes Explained | SUPAC, Variations & Change Control in Pharma

Pharma Hub™ - Drug Master File (DMF) Explained | Drug Master File Types, LOA, Open vs Closed Part & Lifecycle

Pharma Hub™ - How Generic Drugs Get Approved? ANDA Process Explained (Bioequivalence & Patents)

Pharma Hub™ - ICH Quality Guidelines 2026 Explained in 15 Minutes | ICH Quality guidelines Simplified 🧪

Pharma Hub™ - Understanding 21 CFR in Pharmaceuticals | Full Breakdown for Compliance Professionals

Pharma Hub™ - Exhibit Batches in the Pharmaceutical Industry

Pharma Hub™ - WHO Continuous Manufacturing Guidance | TRS 1067 Annex 2 Explained

Pharma Hub™ - New Drugs & Clinical Trial Rules NDCT, Rules 2019

Pharma Hub™ - CDSCO Registration & Licensing: Process, Documents, Cost & Timeline

Pharma Hub™ - ICH M7 - Risk assessment for mutagenic impurities and control strategies

Pharma Hub™ - Fixed-Dose Combination (FDC) Drugs Ban | CDSCO | UPSC | InDepth | Drishti IAS English

Pharma Hub™ - 𝗧𝗵𝗲 𝟯𝟱𝟭(𝗸) 𝗕𝗶𝗼𝘀𝗶𝗺𝗶𝗹𝗮𝗿 𝗕𝗼𝘂𝗻𝗱𝗮𝗿𝗶𝗲𝘀: 𝗗𝗲𝘀𝗶𝗴𝗻 𝗙𝗹𝗲𝘅𝗶𝗯𝗶𝗹𝗶𝘁𝘆, 𝗜𝗻𝘁𝗲𝗿𝗰𝗵𝗮𝗻𝗴𝗲𝗮𝗯𝗶𝗹𝗶𝘁𝘆, & 𝗖𝗼𝗺𝗽𝗮𝗿𝗮𝗯𝗶𝗹𝗶𝘁𝘆

Pharma Hub™ - Reverse Engineering and Q1/Q2 Studies in Generic Drug Development

Pharma Hub™ - FDA Expectations for 505(b)(2) Regulatory Pathway for New Drugs

Pharma Hub™ - Para four filing procedure, and 180 days Exclusivity

Pharma Hub™ - GDF2025-D2S08-Common Clinical Deficiencies in ANDAs Containing Comparative Clinical Endpoint Studies

Pharma Hub™ - How to Obtain Orphan Drug Designation

Pharma Hub™ - Marketing Authorisation in EU| European Medicines Agency (EMA)| MRP, DCP, CP & National Procedure

Pharma Hub™ - Pharma Regulatory Authorities-TGA,MHRA,MCC

Pharma Hub™ - A Global Stamp of Approval: Navigating WHO Prequalification and PIC/S Recognition

Pharma Hub™ - Drug Labeling Explained (REGULATORY AFFAIRS) | USPI, SmPC & PIL Differences (FDA vs EMA)

Pharma Hub™ - Regulatory requirements in ROW countries | Regulatory Affairs | row countries

Pharma Hub™ - CTD Module 2 3 – Quality Overall Summary QOS

Pharma Hub™ - CTD Module 3 CMC Layout Explained | Drug Substance, Drug Product, Stability & Validation

Pharma Hub™ - 3.2.S.7 Stability Explained | CTD Module 3 | CMC Regulatory Affairs

Pharma Hub™ - CTD & eCTD Explained | Structure, Modules, Lifecycle & Industry Use | Regulatory Affairs

Pharma Hub™ - Product-Specific Guidances for Complex Generic Drugs

Pharma Hub™ - Webinar Certificate of Suitability 2.0 (CEP)

Pharma Hub™ - Drug Master File (DMF) Explained | Types, LOA, Process & Regulatory Affairs

Pharma Hub™ - Process of Establishment Registration and Device Listing USFDA|L-2|Steps By Step Easy Process

Pharma Hub™ - How to Perform a Nitrosamine Risk Assessment for Your Drug Product | Complete Step-by-Step Guid

Pharma Hub™ - Is Your Regulatory Intelligence Actually Built for Pharmacovigilance?

Pharma Hub™ - ICH E6 (R2) Explained | GCP Guidelines for Clinical Research, Investigators & Medical Affairs
Pharmaceutics & Formulation DevelopmentQuality Control & Analytical SciencesQuality Assurance & GMPPharmaceutical R&DPharmacology & Pharmaceutical ChemistryPharmaceutical Manufacturing & EngineeringPharmacovigilance & Clinical ResearchGPAT & Competitive Exam PreparationPharma Careers & Professional DevelopmentPharma Marketing & Business ManagementPharmaceutical Industry Insights
